The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein–coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where theymediatemodulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molec-ular switches all contribute to the complex molecular...
The metabotropic glutamate 5 (mGlu5) receptor is a class C G protein-coupled receptor (GPCR) that is...
Metabotropic glutamate receptors (mGluR) belong to the G-protein-coupled receptor (GPCR) family and ...
In recent years, new drug discovery approaches based on novel pharmacological concepts have emerged....
Metabotropic glutamate (mGlu) receptors, which include mGlu1–8 receptors, are a heterogeneous family...
International audienceMetabotropic glutamate (mGlu) receptors respond to glutamate, the major excita...
*S Supporting Information ABSTRACT: Metabotropic glutamate receptor 7 (mGlu7) is a member of the gro...
Metabotropic glutamate receptor 7 (mGlu<sub>7</sub>) is a member of the group III mGlu receptors (mG...
Metabotropic glutamate receptors belong to class C G-protein-coupled receptors and consist of eight ...
Drug discovery programs increasingly are focusing on allosteric modulators as ameans tomodify the ac...
Metabotropic glutamate (mGlu) receptors were discovered in the mid 1980s and originally described as...
Almost 25 years after the first report that glutamate can activate receptors coupled to heterotrimer...
G protein-coupled receptors represent the largest family of druggable targets in the human genome, w...
G-protein coupled receptors (GPCRs) are targets for 1/3 of the drugs available on the market making ...
Metabotropic glutamate (mGlu) receptors are a large, heterogeneous family of G-protein coupled recep...
Background and PurposeAllosteric modulation of the mGlu2 receptor is a potential strategy for treatm...
The metabotropic glutamate 5 (mGlu5) receptor is a class C G protein-coupled receptor (GPCR) that is...
Metabotropic glutamate receptors (mGluR) belong to the G-protein-coupled receptor (GPCR) family and ...
In recent years, new drug discovery approaches based on novel pharmacological concepts have emerged....
Metabotropic glutamate (mGlu) receptors, which include mGlu1–8 receptors, are a heterogeneous family...
International audienceMetabotropic glutamate (mGlu) receptors respond to glutamate, the major excita...
*S Supporting Information ABSTRACT: Metabotropic glutamate receptor 7 (mGlu7) is a member of the gro...
Metabotropic glutamate receptor 7 (mGlu<sub>7</sub>) is a member of the group III mGlu receptors (mG...
Metabotropic glutamate receptors belong to class C G-protein-coupled receptors and consist of eight ...
Drug discovery programs increasingly are focusing on allosteric modulators as ameans tomodify the ac...
Metabotropic glutamate (mGlu) receptors were discovered in the mid 1980s and originally described as...
Almost 25 years after the first report that glutamate can activate receptors coupled to heterotrimer...
G protein-coupled receptors represent the largest family of druggable targets in the human genome, w...
G-protein coupled receptors (GPCRs) are targets for 1/3 of the drugs available on the market making ...
Metabotropic glutamate (mGlu) receptors are a large, heterogeneous family of G-protein coupled recep...
Background and PurposeAllosteric modulation of the mGlu2 receptor is a potential strategy for treatm...
The metabotropic glutamate 5 (mGlu5) receptor is a class C G protein-coupled receptor (GPCR) that is...
Metabotropic glutamate receptors (mGluR) belong to the G-protein-coupled receptor (GPCR) family and ...
In recent years, new drug discovery approaches based on novel pharmacological concepts have emerged....